UPDATE 1-FDA approves cheaper Botox rival to treat frown lines
February 01, 2019 at 17:48 PM EST
An injection to treat forehead wrinkles is set to rival Allergan's Botox after U.S. regulators approved Evolus Inc's cheaper treatment on Friday, sending its shares up about 5 percent after the bell.